OR WAIT null SECS
March 05, 2020
The technology enables the rapid production of large numbers of recombinant antibodies at 80-mL scale.
March 02, 2020
Single-use and modular systems will meet demand for rapid implementation at different scales.
February 27, 2020
The company presented data on its G2 glycosylation studies at the 15th European Conference on Fungal Genetics in Rome on Feb. 19, 2020.
October 28, 2019
GE Healthcare Life Sciences’ KUBio box is an integrated, flexible biomanufacturing environment for viral vector-based gene therapies.
September 01, 2019
In an effort to secure a continuous, sustainable supply of an important vaccine ingredient, Agenus is turning to a plant cell-based cell culture method for production.
Innovation in manufacturing technologies must occur to ensure the availability of gene and cell therapies.
The evolution of cell-culture technology is driving the need for improvements in modeling solutions.
June 01, 2019
As cost and time pressures within biopharma are on the rise, innovative expression systems may offer companies a good opportunity to streamline processes early on.
January 25, 2019
G-CON will provide a complete cleanroom infrastructure for GE Healthcare’s cell therapy and viral vector production platforms that will simplify early-stage manufacturing efforts.
January 15, 2019
The agreement gives Sanofi access to Biomunex’s proprietary bi- and multi-specific-antibody-generating platform.